These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 26484530)

  • 1. Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus Infectivity.
    Acharya D; Paul AM; Anderson JF; Huang F; Bai F
    PLoS Negl Trop Dis; 2015; 9(10):e0004139. PubMed ID: 26484530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice.
    Ashbrook AW; Burrack KS; Silva LA; Montgomery SA; Heise MT; Morrison TE; Dermody TS
    J Virol; 2014 Nov; 88(21):12180-92. PubMed ID: 25142598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology.
    Jones JE; Long KM; Whitmore AC; Sanders W; Thurlow LR; Brown JA; Morrison CR; Vincent H; Peck KM; Browning C; Moorman N; Lim JK; Heise MT
    mBio; 2017 Nov; 8(6):. PubMed ID: 29138302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chikungunya virus induces a more moderate cytopathic effect in mosquito cells than in mammalian cells.
    Li YG; Siripanyaphinyo U; Tumkosit U; Noranate N; A-nuegoonpipat A; Tao R; Kurosu T; Ikuta K; Takeda N; Anantapreecha S
    Intervirology; 2013; 56(1):6-12. PubMed ID: 22907160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the chikungunya virus E1 glycoprotein domain II and hinge influence E2 conformation, infectivity, and virus-receptor interactions.
    Thannickal SA; Battini L; Spector SN; Noval MG; Álvarez DE; Stapleford KA
    J Virol; 2024 Jul; 98(7):e0067924. PubMed ID: 38842335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.
    Silva LA; Khomandiak S; Ashbrook AW; Weller R; Heise MT; Morrison TE; Dermody TS
    J Virol; 2014 Mar; 88(5):2385-97. PubMed ID: 24371059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Use of Chikungunya Virus Replication Templates Utilizing Mammalian and Mosquito RNA Polymerase I-Mediated Transcription.
    Utt A; Rausalu K; Jakobson M; Männik A; Alphey L; Fragkoudis R; Merits A
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31217251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.
    Taylor A; Liu X; Zaid A; Goh LY; Hobson-Peters J; Hall RA; Merits A; Mahalingam S
    mBio; 2017 Feb; 8(1):. PubMed ID: 28223458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4'-Fluorouridine inhibits alphavirus replication and infection
    Yin P; May NA; Lello LS; Fayed A; Parks MG; Drobish AM; Wang S; Andrews M; Sticher Z; Kolykhalov AA; Natchus MG; Painter GR; Merits A; Kielian M; Morrison TE
    mBio; 2024 Jun; 15(6):e0042024. PubMed ID: 38700353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using SHAPE-MaP To Model RNA Secondary Structure and Identify 3'UTR Variation in Chikungunya Virus.
    Madden EA; Plante KS; Morrison CR; Kutchko KM; Sanders W; Long KM; Taft-Benz S; Cruz Cisneros MC; White AM; Sarkar S; Reynolds G; Vincent HA; Laederach A; Moorman NJ; Heise MT
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.
    Pal P; Fox JM; Hawman DW; Huang YJ; Messaoudi I; Kreklywich C; Denton M; Legasse AW; Smith PP; Johnson S; Axthelm MK; Vanlandingham DL; Streblow DN; Higgs S; Morrison TE; Diamond MS
    J Virol; 2014 Aug; 88(15):8213-26. PubMed ID: 24829346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chikungunya Virus Strains from Each Genetic Clade Bind Sulfated Glycosaminoglycans as Attachment Factors.
    McAllister N; Liu Y; Silva LM; Lentscher AJ; Chai W; Wu N; Griswold KA; Raghunathan K; Vang L; Alexander J; Warfield KL; Diamond MS; Feizi T; Silva LA; Dermody TS
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
    Akhrymuk I; Lukash T; Frolov I; Frolova EI
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.
    Bouma EM; van de Pol DPI; Sanders ID; Rodenhuis-Zybert IA; Smit JM
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
    Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R
    Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Chikungunya Virus Variants at the E1-E1 Interglycoprotein Spike Interface Impact Virus Attachment and Inflammation.
    Rangel MV; McAllister N; Dancel-Manning K; Noval MG; Silva LA; Stapleford KA
    J Virol; 2022 Feb; 96(4):e0158621. PubMed ID: 34935436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G3BP/Rin-Binding Motifs Inserted into Flexible Regions of nsP2 Support RNA Replication of Chikungunya Virus.
    Wang S; Merits A
    J Virol; 2022 Nov; 96(21):e0127822. PubMed ID: 36226983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Host Factors Interact with the Hypervariable Domain of Chikungunya Virus nsP3 and Determine Viral Replication in Cell-Specific Mode.
    Meshram CD; Agback P; Shiliaev N; Urakova N; Mobley JA; Agback T; Frolova EI; Frolov I
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chikungunya Virus' High Genomic Plasticity Enables Rapid Adaptation to Restrictive A549 Cells.
    De Caluwé L; Heyndrickx L; Coppens S; Vereecken K; Quiñones-Mateu ME; Merits A; Ariën KK; Bartholomeeusen K
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.